InvestorsHub Logo
Followers 14
Posts 818
Boards Moderated 1
Alias Born 11/13/2019

Re: None

Tuesday, 07/11/2023 8:58:16 AM

Tuesday, July 11, 2023 8:58:16 AM

Post# of 437
$CVM - Up 8% Pre-Market/ Current Price $2.66
Reports Phase 3 Tumor PD-L1 Biomarker Data Demonstrate Multikine’s Increased Efficacy and Points to Potential for Combination With Checkpoint Inhibitors for Head & Neck Cancer

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.